Gilead (GILD) Announced Interim Phase 2 Data on Hepatitis Drugs

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. IBM
4. SPCX
5. ACN
6. NVDA
7. PRIM
8. META
9. SPY
10. DPZ

Go back to Gilead (GILD) Announced Interim Phase 2 Data on Hepatitis Drugs
Gilead Sciences (NASDAQ: GILD) Delayed: 126.05 +1.18 (0.94%)
Previous Close $124.87    52 Week High $108.63 
Open $126.63    52 Week Low $71.39 
Day High $126.63    P/E 69.64 
Day Low $124.44    EPS $1.81 
Volume 963,527